Tietueen sitaatit

APA-viite (7. p.)
Diral, E., Furnari, G., Furnari, G., Bruno, A., Greco, R., Clerici, D., . . . Lupo-Stanghellini, M. T. (2024). Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: A real-world, single-center experience. Frontiers Media S.A.
Chicago-viite (17. p.)
Diral, Elisa, et al. Sorafenib Maintenance in FLT3-ITD Mutated AML After Allogeneic HCT: A Real-world, Single-center Experience. Frontiers Media S.A, 2024.
MLA-viite (9. p.)
Diral, Elisa, et al. Sorafenib Maintenance in FLT3-ITD Mutated AML After Allogeneic HCT: A Real-world, Single-center Experience. Frontiers Media S.A, 2024.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.